Group One Trading »

Aeglea Biotherapeutics shares owned by Group One Trading

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Group One Trading from 13F filings

Historical chart of Group One Trading investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Group One Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Group One Trading

Quarter filed Position value Share count Share price at filing
2025-12-31 $13k 400 32.76

More positions owned by Group One Trading

Tesla Motors Inc cmn Call Option
Meta Platforms Cl A Call Option
Unitedhealth Group Inc option Call Option
Nvidia Corp option Call Option
Spdr Gold Tr Gold Shs Call Option
Lilly Eli & Co option Call Option
Alibaba Group Hldg Sponsored Ads Call Option
Apple Inc option Call Option
Tesla Motors Inc cmn Put Option
Microsoft Corp Call Option
Robinhood Mkts Com Cl A Call Option
Strategy Cl A New Put Option
Strategy Cl A New Call Option
Taiwan Semiconductor Mfg Sponsored Ads Put Option
Palantir Technologies Cl A Call Option

View all positions for Group One Trading

Top funds holding Aeglea Biotherapeutics

FMR
BlackRock
Rtw Investments
Vanguard Group
Fairmount Funds Management
VR Adviser
Capital Research and Management Company - Division 3
Perceptive Advisors
Driehaus Capital Management
Commodore Capital
State Street Corporation
TCG Crossover Management
Tang Capital Management
Geode Capital Management
Braidwell

View all funds holding Aeglea Biotherapeutics